Extended Abstract
OUTCOME OF NEWER FIBRIN SPECIFIC THROMBOLITIC AGENT IN STEMI IN A COMMUNITY HOSPITAL: NEPAL
Author(s): S. Silwal*, A. Basnet and S. chaulagain
ThapaKeywords: Tenecteplase, Coronary Angiography, Percutaneous Coronary intervention, Thrombolysis
Corresponding Author: Dr. Shivaji Bikram Silwal, Consultant Cardiologist,
Head, Department of Cardiology , Scheer Memorial Hospital, Banepa, Kavre
BACKGROUND: In the absence of contraindications, fibrinolytic therapy is administered to ST-elevation MI (STEMI) patients with symptom onset within 12 hours after diagnosis of STEMI in partly limited availability of primary percutaneous coronary intervention (PCI) hospital. Reperfusion treatment in acute STEMI represents the main indication for thrombolytic therapy in a community hospital set up.
OBJECTIVE: To study newer fibrin specific thrombolytic agent for the management of acute STEMI.
RESULT: In our study, we had 38 pati.. View More»